However, although liver transplant and heart transplant recipients appeared to be the optimal control group to differentiate the relative effects of CKD and immune suppression on bone FGF23 expression in renal transplant recipients, it is important to note that these patients also had decreased renal function, with an average GFR of 73 ml/min/1.73m2. Here, FGF23 is linked to chronic kidney disease.